New Recruiting Trial: Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube

WHY IT MATTERS

This trial could help patients with conditions treated by avacopan who have difficulty swallowing or need alternative delivery methods access this medication more easily.

Researchers at Mayo Clinic are testing a new way to give a medicine called avacopan to patients who cannot swallow pills normally. Instead of swallowing, the medicine will be delivered through a tube that goes down the nose into the stomach. This Phase 1 trial is looking at how the body absorbs and processes this emulsified (liquid) form of the drug.

NCT ID: NCT07556484 Title: Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube Status: RECRUITING Phase: PHASE1 Sponsor: Mayo Clinic Start date: 2026-05-01 URL: https://clinicaltrials.gov/study/NCT07556484 Source: UniteRare clinical trials database